Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ

Revenue (LTM)

$67M

Net Income (LTM)

$-166M

+43.2% YoY

Free Cash Flow

$-171M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.2B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	67
Gross Profit	0	0	0	0	67
Operating Income	-119	-217↓82.3%	-227↓5.0%	-300↓31.8%	-191↑36.2%
Net Income	-118	-159↓34.7%	-237↓49.2%	-292↓23.4%	-166↑43.2%
EBITDA	-119	-207↓74.7%	-226↓9.0%	-248↓9.6%	-186↑24.8%
EPS Diluted	-2.87	-3.72↓29.6%	-4.48↓20.4%	-4.47↑0.2%	-2.33↑47.9%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	55	60↑9.1%	43↓28.2%	28↓34.9%	34↑20.9%
Total Current Assets	345	351↑1.6%	452↑28.8%	497↑9.9%	386↓22.3%
Total Assets	366	472↑29.1%	553↑17.3%	562↑1.5%	430↓23.4%
Total Current Liabilities	29	44↑53.6%	57↑28.9%	69↑22.5%	53↓24.0%
Total Liabilities	32	108↑234.2%	119↑11.1%	125↑4.4%	93↓25.3%
Total Equity	309	364↑17.9%	434↑19.2%	437↑0.8%	337↓22.9%
Total Debt	2	46↑2196.7%	47↑3.1%	46↓3.3%	43↓6.8%
Net Debt	-53	-14↑73.5%	4↑130.3%	18↑316.4%	9↓50.7%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-87	-154↓77.5%	-164↓6.3%	-208↓26.9%	-171↑17.8%
Capital Expenditure	-1	-6↓705.7%	-3↑58.3%	-1↑77.1%	-0↑62.1%
Free Cash Flow	-88	-160↓82.9%	-166↓3.8%	-208↓25.3%	-171↑17.9%
Stock-Based Comp	23	36↑54.4%	47↑31.1%	55↑17.0%	67↑22.7%
Net Change in Cash	-11	6↑156.3%	-17↓367.5%	-15↑11.3%	6↑138.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance